Ansarada is growing cash receipts, while Control Bionics is only growing expenditures…
Ansarada (ASX: AND)
Ansarada shares continue to trade on around 4x revenue, which is very low compared to other ASX listed software stocks.
Yesterday, I appeared on Ausbiz’s the Call to discuss a range of stocks with Adam Dawes and Nadine Blaney. Of particular interest may be our discussions of Ansarada (ASX: AND) and Eroad (ASX:ERD). The discussion of Eroad starts at 2 minutes and 40 seconds, in the video below, while the discussion of Ansarada starts at … Continued